levodopa has been researched along with clonidine in 132 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 71 (53.79) | 18.7374 |
1990's | 35 (26.52) | 18.2507 |
2000's | 15 (11.36) | 29.6817 |
2010's | 9 (6.82) | 24.3611 |
2020's | 2 (1.52) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Kleinrok, Z; Zebrowska-Lupina, I | 1 |
Ogren, SO; Ross, SB | 1 |
Quik, M; Sourkes, TL | 1 |
Sternon, J | 1 |
Ahlenius, S; Berggren, U; Engel, J; Tallstedt, L | 1 |
Ranta, T; Tuomisto, J | 1 |
Fujiwara, M; Oishi, R; Razzak, A; Ueki, S | 1 |
Boer, PH; Fekkes, D; Korf, J | 1 |
Austin, JH; Fuxe, K; Nygren, LG | 1 |
Ganong, WF | 1 |
Andersson, G; Sjölund, B | 1 |
Laverty, R | 1 |
Dadkar, VN; Dahanukar, SA; Sheth, UK | 1 |
Oppenheim, R; Pittman, R; Ramakrishna, T | 1 |
Bucher, B; Doepfner, W; Jaton, AL; Marbach, P; Ruch, W | 1 |
Strömbom, U; Svensson, TH | 1 |
Sybertz, EJ; Zimmerman, BG | 1 |
Ganong, WF; Grumbach, MM; Holland, FJ; Kaplan, SL; Richards, GE | 1 |
Franz, DN; Hare, BD; Neumayr, RJ | 1 |
Chase, TN; Shoulson, I | 2 |
Rolls, ET; Shaw, SG | 1 |
Nygren, LG; Olson, L | 1 |
Dolphin, AC; Jenner, P; Marsden, CD | 1 |
Gräf, HJ; Horowski, R | 1 |
Trolin, GG | 1 |
Miller, S; Van Der Burg, J; Van Der Meché, F | 1 |
Marsden, CD; Parkes, JD; Tarsy, D | 1 |
Jenner, P; Marsden, CD | 1 |
Monti, JM; Ruiz, M | 1 |
Miyauchi, T; Ozawa, H; Sugawara, K | 1 |
Dinari, G; Kiro, A; Marcus, H; Zahavi, I | 1 |
Bastian, W; Castells, S; Torrado, C; Wisniewski, KE | 1 |
Donaldson, DL; Gifford, R; Hollowell, JG; Moore, KC; Moore, WV | 1 |
Birmaher, B; Dahl, RE; Iyengar, S; Kaufman, J; Perel, JM; Ryan, ND | 1 |
Donaldson, DL; Gifford, RA; Hollowell, JG; Moore, WV; Pan, F; Stevenson, JL | 1 |
Chokroverty, S; Hening, WA; Walters, AS | 1 |
Greiner, HE; Haase, AF; Seyfried, CA | 1 |
Garfinkel, BD; Jensen, JB; Pease, JJ; ten Bensel, R | 1 |
Davis, A; Jenner, P; Marsden, CD | 1 |
King, RG; Rawlow, A | 1 |
Bernasconi, S; Ghizzoni, L; Muto, G; Spaggiari, R; Virdis, R; Volta, C | 1 |
Garfinkel, BD; Jensen, JB | 2 |
Fukuda, H; Ono, H; Tanabe, M | 1 |
Bressman, SB; Greene, PE | 1 |
Arvat, E; Bellone, J; Camanni, F; Ghigo, E; Imperiale, E; Mazza, E; Procopio, M | 1 |
Garfinkel, BD; Jensen, JB; Realmuto, GM; Reeve, E | 1 |
Czyrak, A; Maj, J; Mogilnicka, E | 1 |
Bakchine, S; Benoit, N; Chain, F; Lacomblez, L; Lhermitte, F; Parisot, D | 1 |
Donaldson, DL; Gifford, RA; Hollowell, JG; Moore, WV; Pan, FP | 1 |
Hashimoto, H; Hasui, M; Igarashi, N; Kato, E; Minami, S; Okabe, T; Sato, T | 1 |
Benderli, A; Borochowitz, Z; Heyman, I; Hochberg, Z; Oren, S; Spirer, Z; Vardi, P; Weisman, Y | 1 |
Closse, A; Enz, A; Frick, W; Giger, RK; Jaton, AL; Markstein, R; Vigouret, JM | 1 |
Bercu, BB; Root, AW; Shulman, DI | 1 |
Cella, SG; Lampis, A; Locatelli, V; Loche, S; Müller, EE; Pintor, C | 1 |
Mair, RG; McEntee, WJ | 1 |
Argente, J; Brion, DE; Donnadieu, M; Garnier, P; Job, JC; Liapi, C; Tonon, MC | 1 |
Borrelli, P; Cappa, M; Corda, R; Loche, S; Marini, R; Pintor, C; Porcedda, C | 1 |
Romer, T; Rymkiewicz-Kluczyńska, B; Szarras-Czapnik, M | 1 |
Bercu, BB; Shulman, DI | 1 |
Knip, M; Lautala, P; Leppäluoto, J; Tapanainen, P | 1 |
Kantak, KM; Miczek, KA | 1 |
Conway, BA; Hultborn, H; Kiehn, O; Mintz, I | 1 |
Maj, J; Michaluk, J; Rawłów, A; Rogóz, Z; Skuza, G | 1 |
Bercu, BB; Root, AW; Shulman, D; Spiliotis, BE | 1 |
Farel, PB; McClellan, AD | 1 |
Chalew, SA; Kowarski, AA; Raiti, S; Zadik, Z | 1 |
Evans, WS; Ho, KY; Thorner, MO | 1 |
Blask, DE; Stockmeier, CA | 1 |
Caccia, MR; Mangoni, A | 1 |
Jacobs, BL; Morilak, DA | 1 |
Fechter, LD | 1 |
Andén, NE; Engel, J | 1 |
Johansson, P | 2 |
Feigenbaum, JJ; Fishman, RH; Klawans, HL; Yanai, J | 1 |
Gotlin, RW; Klingensmith, GJ; Radcliffe, J; Slover, RH | 1 |
Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y | 1 |
Brianda, S; Delitala, G; Maioli, M; Mannelli, M; Pacifico, A; Palermo, M | 1 |
Carrillo Domínguez, A; Diéguez López, C; Mendoza Betancor, B; Rodríguez Doreste, OL; Valerón Martel, C | 1 |
Berggren, U; Engel, J | 1 |
Bailey, R; Crisp, E; Jackson, DM; Jenkins, O | 1 |
Pappas, BA; Robinson, TE; Vanderwolf, CH | 1 |
Pirke, KM; Spyra, B | 1 |
Barbieri, C; Caldara, R; Curtarelli, G; Ferrari, C | 1 |
Bercu, BB | 1 |
Moorman, SJ; Whalen, LR | 1 |
Maj, J; Rogóz, Z; Skuza, G | 1 |
Bédard, PJ; Gomez-Mancilla, B | 1 |
Albertsson-Wikland, K; Blethen, SL; Chasalow, FI; Faklis, EJ | 1 |
Enjaume, C; Oliver, I; Pienkowski, C; Rochiccioli, P; Tauber, MT | 1 |
Bordenick, S; Chrousos, GP; Heavner, G; Hintz, R; Marini, JC; Rose, S; Rosenfeld, R | 1 |
Barkan, AL; DeMott-Friberg, R; Jaffe, CA | 1 |
Abe, K; Hanew, K; Sugawara, A; Tanaka, A; Utsumi, A | 1 |
Aimaretti, G; Bartolotta, E; Bellone, J; Bellone, S; Camanni, F; Cappa, M; Dammacco, F; Ghigo, E; Loche, S | 1 |
Bennett, DJ; De Serres, SJ; Stein, RB | 1 |
Beaulieu, I; Castells, S; Gelato, MC; Torrado, C; Wisniewski, KE; Zarny, S | 1 |
Kimber, JR; Mathias, CJ; Watson, L | 1 |
Bennett, RM; Burckhardt, CS; Campbell, SM; Clark, SR; Cook, DM | 1 |
García-Foncillas, J; Roman, J; Salvador, J; Sierrasesúmaga, L; Villaizán, CJ | 1 |
Brotchie, JM; Crossman, AR; Henry, B | 1 |
Barbeau, H; Bouyer, L; Brustein, E; Chau, C; Giroux, N; Reader, TA; Rossignol, S | 1 |
Athanassaki, K; Berdousi, H; Evagelopoulou, C; Kattamis, C; Konstantoura, O; Ladis, V; Palamidou, F; Papatheodorou, A; Theodoridis, C | 1 |
Hering, P; Hokken-Koelega, A; Van de Lely, A; Van den Broeck, J | 1 |
Baranowska, B; Borowiec, M; Radzikowska, M; Roguski, K; Wasilewska-Dziubinska, E | 1 |
Dewar, KM; Stravynski, A | 1 |
Boryczka, AT; Ganong, WF; Grumbach, M; Holland, J; Kaplan, S; Lovinger, R; Reid, IA; Salmon, J; Shackelford, R | 1 |
Hanew, K; Utsumi, A | 1 |
de Rooij, SE; Jansen, PA; Moons, CG; Samson, MM; Verhaar, HJ | 1 |
Fekete, MI; Fülöp, F; Homicskó, KG; Kertész, I; Nagy, GM; Radnai, B; Tóth, BE; Tóth, G | 1 |
Archer, T; Fredriksson, A | 2 |
Antkiewicz-Michaluk, L; Herman, ZS; Obuchowicz, E; Romańska, I | 1 |
Barnes, KM; Baron, J; Coco, M; Jones, J; Nwosu, BU; Yanovski, JA | 1 |
Garabadu, D; Joshi, VK; Krishnamurthy, S; Muruganandam, AV; Singh, GK | 1 |
Hwang, JS; Lee, HS | 1 |
Gerlach, M; Halley, P; Riederer, P; van den Buuse, M | 1 |
Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T | 1 |
Macedo, CR; Macedo, EC; Prado, GF; Silva, AB; Torloni, MR | 1 |
Bhide, N; Bishop, C; Conti, M; George, JA; Hallmark, J; Ostock, CY; Palumbo, N | 1 |
Bohn, E; Falck-Ytter, Y; Fehlings, D; Goren, K; Switzer, L | 1 |
Hayakawa, T; Iwayama, H; Kitagawa, S; Kurahashi, H; Kuroyanagi, Y; Miyamoto, R; Muto, T; Ohashi, W; Okumura, A; Sada, J; Takagi, J | 1 |
12 review(s) available for levodopa and clonidine
Article | Year |
---|---|
The renin-angiotensin system and the central nervous system.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Animals; Blood Pressure; Brain; Clonidine; Dopamine; Growth Hormone; Hypothalamus, Posterior; Levodopa; Medulla Oblongata; Mesencephalon; Norepinephrine; Phenoxybenzamine; Receptors, Adrenergic; Renin; Sympathetic Nervous System; Thirst; Vasopressins | 1977 |
On the roles of dopamine and noradrenaline in animal behaviour.
Topics: Adrenergic alpha-Antagonists; Aggression; Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature Regulation; Cats; Clonidine; Conditioning, Operant; Dopamine; Drinking Behavior; Enzyme Inhibitors; Feeding Behavior; Haplorhini; Humans; Levodopa; Motor Activity; Norepinephrine; Rage; Rats; Self Stimulation; Stereotyped Behavior; Stress, Psychological | 1975 |
Review and videotape recognition of idiopathic restless legs syndrome.
Topics: Anti-Anxiety Agents; Arousal; Baclofen; Benzodiazepines; Bromocriptine; Carbamazepine; Clonidine; Humans; Levodopa; Narcotics; Restless Legs Syndrome; Sleep Stages; Videotape Recording | 1991 |
Treatment of hyperkinetic movement disorders.
Topics: Benzodiazepines; Clonidine; Dystonia; Humans; Levodopa; Movement Disorders | 1990 |
Neuroactive drugs in growth disorders.
Topics: Bromocriptine; Central Nervous System; Child; Clonidine; False Negative Reactions; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Pyridostigmine Bromide | 1990 |
Clonidine treatment in children with short stature.
Topics: Body Height; Bromocriptine; Child; Clonidine; Growth Disorders; Growth Hormone; Humans; Levodopa | 1988 |
Disorders of prolactin and growth hormone secretion.
Topics: Acromegaly; Arginine; Clonidine; Dwarfism; Female; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Lactation; Levodopa; Male; Methyldopa; Physical Exertion; Pituitary Neoplasms; Pregnancy; Prolactin; Propranolol; Reserpine; Sleep; Somatomedins; Thyrotropin-Releasing Hormone | 1985 |
Comparative aspects of central cardiovascular control with special reference to adrenergic mechanisms.
Topics: Amphibians; Animals; Birds; Blood Pressure; Brain; Carbidopa; Cardiovascular Physiological Phenomena; Cardiovascular System; Central Nervous System; Clonidine; Electric Stimulation; Fishes; Levodopa; Reptiles; Sympathomimetics; Vertebrates | 1983 |
Interpretative difficulties with growth hormone provocative retesting in childhood-onset growth hormone deficiency.
Topics: Adult; Arginine; Child; Clonidine; Female; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypopituitarism; Levodopa; Male; Reproducibility of Results | 1999 |
The quest for biological correlates of social phobia: an interim assessment.
Topics: Adrenergic alpha-Agonists; Adult; Animals; Benzodiazepines; Brain; Carbon Dioxide; Clonidine; Epinephrine; Female; Fenfluramine; Gastrointestinal Agents; Human Growth Hormone; Humans; Hydrocortisone; Lactic Acid; Levodopa; Magnetic Resonance Spectroscopy; Male; Monoamine Oxidase Inhibitors; Pentagastrin; Phobic Disorders; Prolactin; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon | 2001 |
Pharmacotherapy for sleep bruxism.
Topics: Amitriptyline; Bromocriptine; Clonidine; Humans; Levodopa; Propranolol; Randomized Controlled Trials as Topic; Sleep Bruxism; Tryptophan | 2014 |
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.
Topics: Baclofen; Botulinum Toxins; Cerebral Palsy; Clonidine; Deep Brain Stimulation; Dystonia; Humans; Injections, Spinal; Levodopa; Neurosurgical Procedures; Trihexyphenidyl | 2021 |
5 trial(s) available for levodopa and clonidine
Article | Year |
---|---|
Clonidine and the anti-parkinsonian response to L-DOPA or piribedil.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Clonidine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Placebos | 1976 |
Effectiveness of growth-promoting therapies. Comparison among growth hormone, clonidine, and levodopa.
Topics: Body Height; Child; Clonidine; Female; Growth Disorders; Growth Hormone; Humans; Levodopa; Male | 1991 |
Manic-like state after bilateral orbitofrontal and right temporoparietal injury: efficacy of clonidine.
Topics: Adult; Behavior; Bipolar Disorder; Brain; Carbamazepine; Clonidine; Cognition; Female; Frontal Lobe; Humans; Levodopa; Orbit; Parietal Lobe; Temporal Lobe; Tomography, X-Ray Computed | 1989 |
Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine.
Topics: Alcohol Amnestic Disorder; Attention; Biogenic Amines; Brain Chemistry; Clonidine; Cognition Disorders; Ephedrine; Humans; Levodopa; Male; Memory; Methoxyhydroxyphenylglycol; Perception; Psychomotor Performance | 1986 |
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Topics: Adrenergic alpha-Agonists; Arginine; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Hypoglycemia; Levodopa; Male; Pyridostigmine Bromide; Secretory Rate; Somatostatin | 1996 |
115 other study(ies) available for levodopa and clonidine
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
The effect of alpha-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain.
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Brain Chemistry; Butyrophenones; Clonidine; Hydroxyindoleacetic Acid; Levodopa; Male; Phenoxybenzamine; Phentolamine; Probenecid; Rats; Reserpine; Serotonin | 1975 |
Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
Topics: Aggression; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain Chemistry; Clonidine; Depression, Chemical; Dopamine beta-Hydroxylase; Humans; Levodopa; Male; Mice; Norepinephrine | 1976 |
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase | 1977 |
[The practitioner and drug-induced, predominantly orthostatic hypotension].
Topics: Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Antipsychotic Agents; Barbiturates; Butyrophenones; Clonidine; Debrisoquin; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypotension, Orthostatic; Levodopa; Meprobamate; Methyldopa; Mineralocorticoids; Monoamine Oxidase Inhibitors; Phenothiazines; Prazosin; Psychotropic Drugs; Reserpine; Vasodilator Agents | 1978 |
The effect of lithium on amphetamine-induced locomotor stimulation.
Topics: Amphetamine; Animals; Apomorphine; Clonidine; Drug Interactions; Female; Levodopa; Lithium; Methyltyrosines; Mice; Motor Activity; Reserpine; Time Factors | 1978 |
Dual action of adrenergic system on the regulation of thyrotrophin secretion in the male rat.
Topics: Animals; Clonidine; Cold Temperature; Dopamine; Fusaric Acid; Levodopa; Male; Methyltyrosines; Norepinephrine; Phenoxybenzamine; Rats; Receptors, Adrenergic; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1979 |
Possible involvement of a central noradrenergic system in automutilation induced by clonidine in mice.
Topics: 5-Hydroxytryptophan; Animals; Brain; Brain Chemistry; Caffeine; Catecholamines; Chlorpromazine; Clonidine; Dose-Response Relationship, Drug; Drug Synergism; Fenclonine; Humans; Levodopa; Male; Methamphetamine; Methyltyrosines; Mice; Phenoxybenzamine; Phentolamine; Reserpine; Self Mutilation; Sympathetic Nervous System; Theophylline | 1977 |
CYCLIC AMP/*SECRETl cyclic AMP into push-pull perfusates in freely moving rats.
Topics: Adenosine; Animals; Brain; Cerebral Ventricles; Clonidine; Cyclic AMP; Dopamine; Histamine; Isoproterenol; Levodopa; Male; Norepinephrine; Perfusion; Rats; Receptors, Adrenergic; Serotonin | 1976 |
A system for measuring the noradrenaline receptor contribution to the flexor reflex.
Topics: Animals; Clonidine; Dose-Response Relationship, Drug; Electric Stimulation; Levodopa; Male; Muscle Contraction; Norepinephrine; Phenoxybenzamine; Posture; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Reflex; Spinal Cord; Stimulation, Chemical; Time Factors; Tryptamines | 1976 |
The ventral spino-olivocerebellar system in the cat. IV. Spinal transmission after administration of clonidine and L-dopa.
Topics: Afferent Pathways; Animals; Cats; Cerebellar Cortex; Clonidine; Electric Stimulation; Evoked Potentials; Hindlimb; Levodopa; Olivary Nucleus; Purkinje Cells; Reflex; Spinal Cord; Synaptic Transmission | 1978 |
Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
Topics: Animals; Apomorphine; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Clonidine; Dopamine; Drug Interactions; Female; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Norepinephrine; Pentylenetetrazole; Phenoxybenzamine; Propranolol; Receptors, Dopamine; Reserpine; Seizures; Tetrabenazine | 1979 |
Experimental studies on hatching behavior in the chick. IV. Evidence for the role of a noradrenergic mechanism.
Topics: Amphetamine; Animals; Brain Chemistry; Catecholamines; Chick Embryo; Clonidine; Eggs; Heart Rate; Levodopa; Movement; Norepinephrine; Reserpine | 1978 |
Adrenergic and dopaminergic control of growth hormone secretion in urethan anesthetized adult male rats.
Topics: Animals; Apomorphine; Clonidine; Dose-Response Relationship, Drug; Growth Hormone; Injections, Intraventricular; Levodopa; Male; Norepinephrine; Phentolamine; Pimozide; Prolactin; Rats; Sympatholytics; Sympathomimetics; Urethane | 1978 |
Antagonism of morphine-induced central stimulation in mice by small doses of catecholamine-receptor agonists.
Topics: Animals; Apomorphine; Brain; Clonidine; Dopamine; Levodopa; Male; Methyltyrosines; Mice; Morphine; Motor Activity; Norepinephrine; Parasympathomimetics | 1978 |
Influence of hypoxic stimulation of carotid body chemoreceptors on clonidine and l-dopa-induced hypotension.
Topics: Animals; Blood Pressure; Carotid Body; Chemoreceptor Cells; Clonidine; Denervation; Dogs; Female; Levodopa; Male; Oxygen; Pressoreceptors | 1978 |
The role of biogenic amines in the regulation of growth hormone and corticotropin secretion in the trained conscious dog.
Topics: Adrenal Cortex Hormones; Animals; Apomorphine; Biogenic Amines; Blood Glucose; Carbidopa; Clonidine; Dogs; Growth Hormone; Levodopa; Male; Pimozide | 1978 |
Depression of sympathetic preganglionic neurons by clonidine: evidence for stimulation of 5-HT receptors.
Topics: Afferent Pathways; Animals; Cats; Clonidine; Intercostal Nerves; Levodopa; Neurons; Receptors, Serotonin; Serotonin; Spinal Cord; Tolazoline | 1978 |
Is the release of noradrenaline necessary for self-stimulation of the brain?
Topics: Amphetamine; Animals; Benserazide; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Clonidine; Disulfiram; Levodopa; Male; Naphazoline; Nerve Endings; Norepinephrine; Oxymetazoline; Phenylephrine; Rats; Receptors, Drug; Reserpine; Self Stimulation | 1976 |
On spinal noradrenaline receptor supersensitivity: correlation between nerve terminal densities and flexor reflexes various times after intracisternal 6-hydroxydopamine.
Topics: Animals; Apomorphine; Body Weight; Cell Count; Clonidine; Dose-Response Relationship, Drug; Hindlimb; Hydroxydopamines; Levodopa; Male; Nerve Endings; Nialamide; Rats; Receptors, Adrenergic; Reflex; Serotonin; Spinal Cord; Time Factors | 1976 |
The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
Topics: Animals; Apomorphine; Clonidine; Dopamine; Drug Interactions; Exploratory Behavior; Levodopa; Male; Methyltyrosines; Mice; Mice, Inbred Strains; Motor Activity; Norepinephrine; Receptors, Drug; Reserpine; Stimulation, Chemical | 1976 |
Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
Topics: Animals; Apomorphine; Benserazide; Clonidine; Dextroamphetamine; Dopamine; Female; Haloperidol; Hypophysectomy; Levodopa; Male; Methyltyrosines; Piribedil; Pituitary Gland; Prolactin; Rats; Reserpine; Sulpiride; Transplantation, Homologous | 1976 |
Involvement of alpha-adrenergic receptors at different levels of the central nervous system in the regulation of blood pressure and heart frequency.
Topics: Animals; Blood Pressure; Central Nervous System; Clonidine; Dopamine; Heart Rate; Hydroxydopamines; Levodopa; Nerve Degeneration; Neurons; Norepinephrine; Pentobarbital; Rats; Receptors, Adrenergic; Serotonin | 1975 |
Locomotion in the cat: basic programmes of movement.
Topics: 5-Hydroxytryptophan; Animals; Cats; Clonidine; Decerebrate State; Forelimb; Gait; Hindlimb; Levodopa; Movement; Spinal Cord; Swimming | 1975 |
Clonidine in Parkinson disease.
Topics: Aged; Antiparkinson Agents; Clonidine; Female; Humans; Hypertension; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic | 1975 |
Dopaminergic mechanisms in patients with extrapyramidal disease.
Topics: Animals; Biogenic Amines; Brain; Caffeine; Clonidine; Dopamine; Drug Evaluation; Drug Therapy, Combination; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parasympatholytics; Parkinson Disease; Piperazines; Piribedil; Pituitary Gland, Anterior; Prolactin; Rats; Receptors, Drug; Stimulation, Chemical | 1975 |
The influence of piribedil (ET495) on components of locomotor activity.
Topics: Amphetamine; Animals; Apomorphine; Brain; Clonidine; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Mice; Motor Activity; Norepinephrine; Piperazines; Piribedil; Reserpine; Time Factors | 1975 |
Reversal of the 6-hydroxydopamine-induced suppression of a CAR by drugs facilitating central catecholaminergic mechanisms.
Topics: Amphetamine; Animals; Avoidance Learning; Behavior, Animal; Catecholamines; Clonidine; Desipramine; Hydroxydopamines; Injections, Intraventricular; Levodopa; Male; Norepinephrine; Phenelzine; Rats | 1975 |
Potentiating effect of lithium chloride on aggressive behavior induced in mice by nialamide plus L-DOPA and by clonidine.
Topics: Aggression; Animals; Brain; Clonidine; Dopamine; Drug Synergism; Humans; Levodopa; Lithium; Male; Mice; Nialamide; Norepinephrine; Serotonin; Time Factors | 1975 |
L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an alpha-2-adrenergic mechanism.
Topics: Animals; Clonidine; Haloperidol; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Ulcer; Yohimbine | 1992 |
Growth hormone deficiency in Down's syndrome children.
Topics: Adolescent; Anthropometry; Child; Child, Preschool; Clonidine; Down Syndrome; Dwarfism, Pituitary; Female; Growth Hormone; Humans; Infant; Insulin-Like Growth Factor I; Levodopa; Male; Thyroid Hormones | 1992 |
Long-term treatment with growth hormone of children with short stature and normal growth hormone secretion.
Topics: Age Determination by Skeleton; Body Height; Child; Clonidine; Female; Growth Disorders; Growth Hormone; Human Growth Hormone; Humans; Levodopa; Male; Recombinant Proteins; Sleep; Time Factors | 1992 |
Psychobiological methodology.
Topics: Child; Child Abuse; Child Abuse, Sexual; Clonidine; Growth Hormone; Humans; Levodopa; Male | 1992 |
Reliability of stimulated and spontaneous growth hormone (GH) levels for identifying the child with low GH secretion.
Topics: Adolescent; Child; Child, Preschool; Clonidine; Female; Growth Disorders; Humans; Levodopa; Male; Reference Values; Somatostatin | 1991 |
Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.
Topics: Animals; Biogenic Amines; Brain; Clonidine; Corpus Striatum; Dopamine; Dopamine Agents; Drug Interactions; Ergolines; Heart; Hypothalamus; Indoles; Levodopa; Male; Motor Activity; Norepinephrine; Oxidopamine; Pyridines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Sulpiride | 1991 |
Growth hormone response patterns in sexually or physically abused boys.
Topics: Adolescent; Child; Child Abuse; Child Abuse, Sexual; Clonidine; Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Male; Sexual Maturation | 1991 |
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride | 1990 |
A novel in vivo test for drugs affecting central serotonergic and adrenergic systems.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Albuterol; Animals; Clonidine; Decerebrate State; Fenfluramine; Levodopa; Male; Muscle Contraction; Neck Muscles; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Sympathetic Nervous System | 1990 |
Growth hormone dysregulation in children with major depressive disorder.
Topics: Brain; Child; Clonidine; Depressive Disorder; Growth Hormone; Humans; Levodopa; Receptors, Adrenergic, alpha; Receptors, Dopamine | 1990 |
Spinal alpha 1- and alpha 2-adrenoceptors mediate facilitation and inhibition of spinal motor transmission, respectively.
Topics: Animals; Clonidine; Clorgyline; Levodopa; Male; Motor Neurons; Piperoxan; Prazosin; Premedication; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Reflex, Monosynaptic; Spinal Cord; Synaptic Transmission | 1990 |
Growth hormone response to L-dopa and clonidine in autistic children.
Topics: Adolescent; Autistic Disorder; Child; Clonidine; Growth Hormone; Humans; Levodopa; Male; Pilot Projects | 1990 |
Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Body Temperature; Calcium Channel Blockers; Clonidine; Dihydropyridines; Hypnotics and Sedatives; Immobilization; Levodopa; Male; Mice; Rats; Rats, Inbred Strains; Reserpine; Species Specificity | 1989 |
Growth hormone secretory profiles: variation on consecutive nights.
Topics: Adolescent; Child; Child, Preschool; Circadian Rhythm; Clonidine; Growth Disorders; Growth Hormone; Humans; Levodopa | 1989 |
Recurrent attacks of vomiting, hypertension and psychotic depression: a syndrome of periodic catecholamine and prostaglandin discharge.
Topics: Adolescent; Adrenocorticotropic Hormone; Arginine Vasopressin; Child, Preschool; Clonidine; Dinoprostone; Dopamine; Epinephrine; Female; Humans; Hypertension; Indomethacin; Levodopa; Metoclopramide; Norepinephrine; Periodicity; Prostaglandins E; Psychotic Disorders; Recurrence; Syndrome; Vomiting | 1988 |
Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands?
Topics: Calcitriol; Calcium; Child; Child, Preschool; Chorionic Gonadotropin; Clonidine; Endocrine Glands; Female; Fibroblasts; Glucose Tolerance Test; Growth Hormone; Hormones; Humans; Hypophosphatemia, Familial; Infant; Insulin; Levodopa; Male; Prolactin; Receptors, Calcitriol; Receptors, Steroid; Testosterone; Thyrotropin; Thyrotropin-Releasing Hormone | 1985 |
Pharmacological profile of the abeorphine 201-678, a potent orally active and long lasting dopamine agonist.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Brain Chemistry; Clonidine; Cyclic AMP; Dopamine; Hypothalamus; In Vitro Techniques; Indoles; Levodopa; Male; Motor Activity; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; Stereotyped Behavior; Substantia Nigra | 1986 |
Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
Topics: Adolescent; Arginine; Child; Clonidine; Dopamine; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Levodopa; Male; Receptors, Adrenergic, alpha | 1986 |
Plasma growth hormone releasing factor levels in children: physiological and pharmacologically induced variations.
Topics: Amino Acids; Child; Child, Preschool; Clonidine; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Sleep; Stress, Physiological | 1986 |
Growth hormone response to growth hormone releasing hormone 1-40 in Turner's syndrome.
Topics: Adolescent; Adult; Clonidine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Peptide Fragments; Turner Syndrome | 1987 |
Comparison of growth hormone responses to classical stimulation tests and to intravenous administration of growth hormone releasing factor (GRF 1-44) in children with growth hormone deficiency.
Topics: Adolescent; Child; Child, Preschool; Clonidine; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Peptide Fragments | 1987 |
Evaluation of growth hormone secretion: provocative testing vs endogenous 24-hour growth hormone profile.
Topics: Adolescent; Arginine; Child; Clonidine; Female; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Levodopa; Male; Pituitary Function Tests; Time Factors | 1987 |
Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
Topics: Adult; Clonidine; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Levodopa; Male; Middle Aged; Radioimmunoassay; Reference Values | 1988 |
Social, motor, and autonomic signs of morphine withdrawal: differential sensitivities to catecholaminergic drugs in mice.
Topics: Animals; Apomorphine; Autonomic Nervous System; Catecholamines; Clonidine; Cocaine; Dextroamphetamine; Levodopa; Mice; Mice, Inbred Strains; Morphine Dependence; Psychomotor Performance; Reaction Time; Social Behavior; Substance Withdrawal Syndrome | 1988 |
Plateau potentials in alpha-motoneurones induced by intravenous injection of L-dopa and clonidine in the spinal cat.
Topics: Action Potentials; Animals; Cats; Clonidine; Decerebrate State; Levodopa; Membrane Potentials; Motor Neurons; Nialamide | 1988 |
Neuroendocrine aspects of attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Growth Hormone; Humans; Levodopa; Male | 1988 |
Central action of the antidepressant drug pirlindole.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Blepharoptosis; Body Temperature; Carbazoles; Cerebral Cortex; Clonidine; Dihydroalprenolol; Levodopa; Male; Mice; Norepinephrine; Prazosin; Rats; Reserpine; Serotonin | 1986 |
Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
Topics: Adolescent; Adult; Arginine; Child; Child, Preschool; Circadian Rhythm; Clonidine; Female; Growth Disorders; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male | 1986 |
Pharmacological activation of locomotor patterns in larval and adult frog spinal cords.
Topics: 2-Aminoadipic Acid; 5-Hydroxytryptophan; Animals; Apomorphine; Aspartic Acid; Benserazide; Clonidine; In Vitro Techniques; Larva; Levodopa; Locomotion; N-Methylaspartate; Nialamide; Rana catesbeiana; Rana pipiens; Spinal Cord | 1985 |
Do short children secrete insufficient growth hormone?
Topics: Adolescent; Adult; Arginine; Body Height; Child; Child, Preschool; Clonidine; Female; Growth Disorders; Growth Hormone; Humans; Insulin; Levodopa; Male; Pituitary Gland; Reference Values; Stimulation, Chemical | 1985 |
Neuropharmacological modification of central catecholamines: effects on pinealectomy-induced convulsions.
Topics: alpha-Methyltyrosine; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Catecholamines; Clonidine; Desipramine; Levodopa; Male; Methyltyrosines; Parathyroid Glands; Pineal Gland; Rats; Reserpine; Seizures; Timolol | 1986 |
Clonidine in essential tremor: preliminary observations from an open trial.
Topics: Aged; Clonidine; Diazepam; Female; Handwriting; Humans; Levodopa; Male; Middle Aged; Piribedil; Tremor | 1985 |
Noradrenergic modulation of sensorimotor processes in intact rats: the masseteric reflex as a model system.
Topics: Animals; Clonidine; Levodopa; Male; Masseter Muscle; Masticatory Muscles; Norepinephrine; Rats; Rats, Inbred Strains; Reflex; Yohimbine | 1985 |
The effects of L0dopa, clonidine, and apomorphine on the acoustic startle reaction in rats.
Topics: Acoustic Stimulation; Animals; Apomorphine; Brain Chemistry; Brain Stem; Cerebral Cortex; Clonidine; Corpus Striatum; Diencephalon; Dopamine; Drug Interactions; Hydroxyindoleacetic Acid; Levodopa; Male; Norepinephrine; Rats; Receptors, Drug; Reflex, Startle; Reserpine; Serotonin; Stimulation, Chemical | 1974 |
Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
Topics: 5-Hydroxytryptophan; Acetamides; Animals; Apomorphine; Brain Chemistry; Clonidine; Corpus Striatum; Dopamine; Hydrazines; Levodopa; Methyldopa; Methyltyrosines; Movement; Nialamide; Norepinephrine; Octopamine; Rats; Receptors, Drug; Reflex; Reserpine; Spinal Cord; Stimulation, Chemical; Tyramine; Tyrosine | 1974 |
The relative importance of dopamine and norepinephrine in mediating locomotor activity.
Topics: Adrenergic Antagonists; Amphetamines; Animals; Apomorphine; Biomechanical Phenomena; Brain Chemistry; Catecholamines; Clonidine; Corpus Striatum; Dopamine; Droxidopa; Isoproterenol; Levodopa; Limbic System; Locomotion; Neural Pathways; Neurotransmitter Agents; Norepinephrine; Nucleus Accumbens; Propranolol; Receptors, Dopamine; Reserpine; Serotonin; Serotonin Antagonists; Substantia Nigra; Tetrahydronaphthalenes | 1983 |
A comparison of clonidine and standard provocative agents of growth hormone.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Arginine; Blood Glucose; Child; Clonidine; Female; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Levodopa; Male; Stimulation, Chemical | 1984 |
Clonidine therapy for tardive dyskinesia and related syndromes.
Topics: Adult; Aged; Clonidine; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders | 1984 |
Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
Topics: Adult; Apomorphine; Benzodiazepinones; Clonidine; Growth Hormone; Humans; Kinetics; Levodopa; Male; Parasympatholytics; Pirenzepine; Prolactin; Receptors, Cholinergic | 1983 |
[Evaluation of growth hormone stimulation tests using clonidine, glucagon, propanolol, hypoglycemia, arginine and L-dopa in 267 children of short stature].
Topics: Arginine; Child; Clonidine; Dwarfism; Glucagon; Growth Hormone; Humans; Hypoglycemia; Levodopa; Propranolol; Sleep; Stimulation, Chemical | 1984 |
Effects of lithium on behaviour and central monoamines.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Catecholamines; Clonidine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Lithium; Locomotion; Mice; Motor Activity; Rats | 1980 |
Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
Topics: Animals; Apomorphine; Benserazide; Body Temperature Regulation; Brain; Clonidine; Dihydroxyphenylalanine; Dopamine; Humans; Levodopa; Male; Mice; Motor Activity; Norepinephrine; Substance Withdrawal Syndrome | 1981 |
Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Atropine; Cerebral Cortex; Clonidine; Dextroamphetamine; Evoked Potentials; Levodopa; Lysergic Acid Diethylamide; Motor Activity; Phenethylamines; Rats; Receptors, Cholinergic; Reserpine | 1980 |
Catecholamine turnover in the brain and the regulation of luteinizing hormone and corticosterone in starved male rats.
Topics: Albuterol; Animals; Apomorphine; Brain; Catecholamines; Clonidine; Corticosterone; Dopamine; Hypothalamus; Levodopa; Luteinizing Hormone; Male; Median Eminence; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Starvation | 1982 |
Central cardiovascular effects of L-DOPA and clonidine in the lizard, Agama caudospinosa.
Topics: Animals; Benserazide; Blood Pressure; Blood-Brain Barrier; Brain; Carbidopa; Catecholamines; Clonidine; Heart Rate; Hemodynamics; Levodopa; Lizards; Myocardium | 1982 |
Growth hormone secretion in hypertensive patients: evidence for a derangement in central adrenergic function.
Topics: Adult; Clonidine; Female; Growth Hormone; Humans; Hypertension; Levodopa; Male; Middle Aged; Prolactin; Stimulation, Chemical | 1980 |
Neurosecretory dysfunction and parasellar lesions.
Topics: Adolescent; Arginine; Child; Clonidine; Growth Disorders; Growth Hormone; Humans; Hypopituitarism; Hypothalamic Diseases; Insulin; Levodopa; Sella Turcica | 1994 |
A model system to determine the effects of specific neurotransmitters on segmental reflexes in the spinal cord of the rat.
Topics: Animals; Clonidine; Decerebrate State; Dopamine; Electromyography; Electrophysiology; Female; Hindlimb; Levodopa; Models, Neurological; Muscle Contraction; Nerve Fibers; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Phentolamine; Rats; Rats, Sprague-Dawley; Reflex; Spinal Cord; Sympathectomy, Chemical | 1993 |
Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
Topics: 2-Amino-5-phosphonovalerate; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Antipsychotic Agents; Biogenic Monoamines; Catalepsy; Central Nervous System Agents; Clonidine; Levodopa; Male; Methyltyrosines; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reserpine; Tyrosine 3-Monooxygenase | 1993 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agents; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Meperidine; Methoxydimethyltryptamines; Neurotransmitter Agents; Yohimbine | 1993 |
Circulating growth hormone isoforms in girls with Turner's syndrome.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Blood Specimen Collection; Child; Child, Preschool; Chromatography, Affinity; Clonidine; Cross Reactions; Female; Growth Disorders; Growth Hormone; Humans; Levodopa; Male; Pituitary Gland; Radioimmunoassay; Reference Values; Sex Characteristics; Turner Syndrome | 1994 |
[Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient].
Topics: Adolescent; Age Determination by Skeleton; Arginine; Betaxolol; Child; Child, Preschool; Clonidine; Confidence Intervals; Data Interpretation, Statistical; Female; Glucagon; Growth Disorders; Growth Hormone; Humans; Insulin; Levodopa; Male; Normal Distribution; Ornithine; Propranolol; Puberty; Radioimmunoassay; Retrospective Studies; Sensitivity and Specificity | 1993 |
The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
Topics: Adolescent; Arginine; Body Height; Child; Child, Preschool; Clonidine; Female; Growth Disorders; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Osteogenesis Imperfecta; Pilot Projects | 1993 |
The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects.
Topics: Adult; Clonidine; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Kinetics; Levodopa; Peptide Fragments | 1996 |
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Topics: Adolescent; Arginine; Child; Child, Preschool; Clonidine; Exercise; Female; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Pyridostigmine Bromide; Reproducibility of Results | 1996 |
Regulation of soleus muscle spindle sensitivity in decerebrate and spinal cats during postural and locomotor activities.
Topics: Action Potentials; Afferent Pathways; Animals; Cats; Clonidine; Decerebrate State; Electrophysiology; Levodopa; Motor Activity; Motor Neurons, Gamma; Muscle Contraction; Muscle, Skeletal; Posture; Sympatholytics | 1996 |
Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation.
Topics: Anthropometry; Child, Preschool; Clonidine; Down Syndrome; Dwarfism, Pituitary; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamic Diseases; Hypothalamo-Hypophyseal System; Infant; Levodopa; Male; Reference Values | 1996 |
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
Topics: Adrenergic alpha-Agonists; Atrophy; Autonomic Nervous System Diseases; Clonidine; Diagnosis, Differential; Dopamine; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Middle Aged; Norepinephrine; Parkinson Disease | 1997 |
Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia.
Topics: Adult; Clonidine; Dopamine Agents; Female; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Insulin-Like Growth Factor I; Levodopa; Middle Aged; Rheumatic Diseases; Sympatholytics | 1997 |
Growth and growth hormone secretion in children with cancer treated with chemotherapy.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Height; Child; Child, Preschool; Clonidine; Dactinomycin; Dopamine Agents; Female; Follow-Up Studies; Growth; Growth Disorders; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Male; Neoplasms; Prospective Studies; Remission Induction; Retrospective Studies; Sex Factors; Time Factors | 1997 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
Pharmacological activation and modulation of the central pattern generator for locomotion in the cat.
Topics: 5-Hydroxytryptophan; Animals; Cats; Clonidine; Denervation; Dopamine Agents; Electromyography; Excitatory Amino Acid Agonists; Glutamic Acid; Levodopa; Locomotion; Methoxamine; Motor Neurons; Muscle, Skeletal; N-Methylaspartate; Norepinephrine; Periodicity; Reflex; Serotonin; Spinal Cord; Sympatholytics; Sympathomimetics; Synaptic Transmission | 1998 |
Growth and management of short stature in thalassaemia major.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Body Height; Child; Clonidine; Female; Growth Disorders; Human Growth Hormone; Humans; Insulin; Levodopa; Male; Puberty, Delayed | 1998 |
The role of VIP and somatostatin in the control of GH and prolactin release in anorexia nervosa and in obesity.
Topics: Adolescent; Adult; Anorexia Nervosa; Case-Control Studies; Clonidine; Female; Gonadotropin-Releasing Hormone; Human Growth Hormone; Humans; Levodopa; Obesity; Prolactin; Somatostatin; Vasoactive Intestinal Peptide | 2000 |
Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Carbidopa; Catecholamines; Clonidine; Dogs; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Growth Hormone; Hypothalamo-Hypophyseal System; Injections, Intraventricular; Levodopa; Male; Neurons; Norepinephrine; Pimozide; Receptors, Adrenergic; Sympathetic Nervous System | 1976 |
The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
Topics: Adult; Arginine; Clonidine; Drug Interactions; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Insulin; Kinetics; Levodopa; Male | 2002 |
Growth-hormone release to clonidine and the clinical response to levodopa in parkinsonism.
Topics: Aged; Antiparkinson Agents; Benserazide; Clonidine; Female; Growth Hormone; Humans; Levodopa; Male; Parkinsonian Disorders | 2002 |
Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Binding Sites; Binding, Competitive; Brain; Carbidopa; Clonidine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Isoquinolines; Kinetics; Lactation; Levodopa; Male; Mazindol; Median Eminence; Methyldopa; Pituitary Gland; Pituitary Gland, Posterior; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reserpine | 2003 |
An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Clonidine; Dopamine; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Guanfacine; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred C57BL; Neostriatum; Neurons; Parkinsonian Disorders; Prazosin; Receptors, Adrenergic, alpha-2; Synaptic Transmission; Yohimbine | 2003 |
Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Dopamine; Homovanillic Acid; Immunohistochemistry; Levodopa; Male; Mice; MPTP Poisoning; Neuropeptide Y; Neuroprotective Agents; Selegiline; Serotonin | 2003 |
Short stature with normal growth hormone stimulation testing: lack of evidence for partial growth hormone deficiency or insensitivity.
Topics: Adolescent; Adrenergic alpha-Agonists; Arginine; Body Weight; Child; Clonidine; Dwarfism, Pituitary; Female; Humans; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Retrospective Studies | 2004 |
Postnatal iron overload destroys NA-DA functional interactions.
Topics: Adrenergic Agents; Adrenergic alpha-Agonists; Animals; Animals, Newborn; Benzylamines; Clonidine; Corpus Striatum; Denervation; Dopamine; Dopamine Agents; Iron Overload; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Norepinephrine | 2007 |
Antidepressant activity of Asparagus racemosus in rodent models.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-Agonists; Aggression; Animals; Antidepressive Agents; Antioxidants; Asparagus Plant; Clonidine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Head Movements; Helplessness, Learned; Hippocampus; Hyperkinesis; Levodopa; Lipid Peroxidation; Male; Medicine, Ayurvedic; Mice; Neostriatum; Plant Extracts; Plant Roots; Rats; Superoxide Dismutase; Swimming | 2009 |
Influence of body mass index on growth hormone responses to classic provocative tests in children with short stature.
Topics: Administration, Oral; Body Mass Index; Child; Clonidine; Dwarfism, Pituitary; Female; Growth Hormone; Humans; Injections, Intravenous; Insulin; Levodopa; Male; Reproducibility of Results; Retrospective Studies; Stimulation, Chemical | 2011 |
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.
Topics: Adrenergic Agents; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antiparkinson Agents; Benserazide; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Facial Asymmetry; Idazoxan; Levodopa; Locomotion; Oxidopamine; Parkinson Disease; Piribedil; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Statistics, Nonparametric; Upper Extremity | 2013 |
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture | 2013 |
Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleus.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antiparkinson Agents; Clonidine; Dyskinesia, Drug-Induced; Imidazoles; Levodopa; Locus Coeruleus; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2 | 2015 |
Insulin-like growth factor-1 level is a poor diagnostic indicator of growth hormone deficiency.
Topics: Algorithms; Arginine; Biomarkers; Body Height; Child; Child, Preschool; Clonidine; Cross-Sectional Studies; Diagnostic Screening Programs; Female; Growth Disorders; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Male; Predictive Value of Tests; Prospective Studies; ROC Curve | 2021 |